Exceptional response to nivolumab of a heavily pre-treated patient with metastatic renal-cell cancer: from a case report to molecular investigation and future perspectives

Immunotherapy may result in long-lasting exceptional clinical responses, the molecular background of which is inadequately understood. Here, we present the case of a 63-year-old patient with a past medical history of renal cancer who relapsed many years later. Several treatment lines were administer...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimitrakopoulos, Foteinos-Ioannis D., Kourea, Eleni, Nasioulas, George, Papadopoulou, Eirini, Nikolakopoulos, Achilles, Spyropoulou, Despoina, Kottorou, Anastasia, Karatzas, Andreas, Kalofonos, Haralabos P., Koutras, Angelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425249/
https://www.ncbi.nlm.nih.gov/pubmed/32849917
http://dx.doi.org/10.1177/1758835920946152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425249/
https://www.ncbi.nlm.nih.gov/pubmed/32849917
http://dx.doi.org/10.1177/1758835920946152

Ejemplares similares